{
    "organizations": [],
    "uuid": "21222a794097b45828807faae088f07d292ca4de",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-guilin-sanjin-pharmaceuticals-prel/brief-guilin-sanjin-pharmaceuticals-prelim-2017-net-profit-up-18-3-pct-y-y-idUSH9N1QG005",
    "ord_in_thread": 0,
    "title": "BRIEF-Guilin Sanjin Pharmaceutical's Prelim 2017 Net Profit Up 18.3 Pct Y/Y",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 27 (Reuters) - Guilin Sanjin Pharmaceutical Co Ltd :\n* SAYS PRELIM 2017 NET PROFIT UP 18.3 PERCENT Y/Y AT 465.7 MILLION YUAN ($73.83 million) Source text in Chinese: bit.ly/2t05gLF Further company coverage: ($1 = 6.3079 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)\n ",
    "published": "2018-02-27T16:18:00.000+02:00",
    "crawled": "2018-02-28T12:44:12.020+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "guilin",
        "sanjin",
        "pharmaceutical",
        "co",
        "ltd",
        "say",
        "prelim",
        "net",
        "profit",
        "percent",
        "million",
        "yuan",
        "million",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "chinese",
        "yuan",
        "renminbi",
        "reporting",
        "hong",
        "kong",
        "newsroom"
    ]
}